Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Depreciation and Depletion: 2020-2022

Historic Depreciation and Depletion for Outlook Therapeutics (OTLK) over the last 3 years, with Sep 2022 value amounting to $163,625.

  • Outlook Therapeutics' Depreciation and Depletion was N/A to $40,906 in Q3 2020 from the same period last year, while for Sep 2020 it was $219,416, marking a year-over-year change of. This contributed to the annual value of $163,625 for FY2022, which is negligibly% changed negligibly from last year.
  • As of FY2022, Outlook Therapeutics' Depreciation and Depletion stood at $163,625, which was up 0.00% from $163,624 recorded in FY2021.
  • Outlook Therapeutics' Depreciation and Depletion's 5-year high stood at $219,416 during FY2020, with a 5-year trough of $163,624 in FY2021.
  • Over the past 3 years, Outlook Therapeutics' median Depreciation and Depletion value was $163,625 (recorded in 2022), while the average stood at $182,222.
  • As far as peak fluctuations go, Outlook Therapeutics' Depreciation and Depletion declined by 25.43% in 2021, and later grew by 0.00% in 2022.
  • Outlook Therapeutics' Depreciation and Depletion (Yearly) stood at $219,416 in 2020, then dropped by 25.43% to $163,624 in 2021, then increased by 0.00% to $163,625 in 2022.